Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

Dr. Sheldon Pinnell, The Founding Father Of Topical Antioxidants, Leading Scientist Behind SkinCeuticals, And Chief Emeritus Of The Division Of Dermatology At Duke University, Dies At 76

Dermatology Community Loses Leader in Field of Antioxidant Technology & Skin Cancer Prevention


News provided by

SkinCeuticals

Jul 12, 2013, 09:01 ET

Share this article

Share toX

Share this article

Share toX

NEW YORK, July 12, 2013 /PRNewswire/ -- Dr. Sheldon Pinnell, an internationally eminent scientist, dermatologist, leading scientist behind L'Oreal-owned SkinCeuticals, and J. Lamar Callaway Professor Emeritus of Dermatology and Chief Emeritus of the Division of Dermatology at Duke University, passed away peacefully in Durham, North Carolina on Thursday, July 4, 2013 just as the fireworks began to sparkle in celebration of Independence Day. He was 76.

(Photo:  http://photos.prnewswire.com/prnh/20130712/NY45730)

Continue Reading

Dr. Pinnell's investigative research has changed the way the world uses topical antioxidants today.  As the founding father of topical antioxidants, he was the first to patent a stable form of vitamin C proven through peer-reviewed research to effectively penetrate skin, delivering eight times the skin's natural antioxidant protection.

Before helping to shape the cosmeceutical industry, Dr. Sheldon Pinnell led major advances in the understanding of skin biology and the pathogenesis of skin diseases. Early in his career, he made seminal contributions to the understanding of Ehlers-Danlos Syndrome and the role of vitamin C in collagen biosynthesis. Dr. Pinnell has been globally recognized for his contributions to science and skincare, most recently receiving an honorary membership to the Society for Investigative Dermatology. 

Over his lifetime, he also received numerous medical and scientific awards including The Best Doctors in America, The International Who's Who in Medicine, Who's Who in Science and Engineering, and Who's Who in America. Dr. Pinnell has published more than 200 scientific articles in peer-reviewed journals on dermatology topics such as photoaging, collagen synthesis, UV protection, topical vitamin C, and other antioxidants.  Dr. Pinnell also authored approximately 20 book chapters and holds ten patents.

"It is our greatest privilege to have been able to help Dr. Pinnell bring his discovery of topical antioxidants to life.  Prior to the introduction of topical vitamin C in the early 1990s, skincare professionals were largely limited to sunscreens to protect against the deleterious effects of the sun.  It was Dr. Pinnell who gave the medical community the confidence to transform the approach to at-home skincare.  We are fortunate to have known Dr. Pinnell as a scientist, a family man, and a dear friend. His life lessons and infectious spirit will remain with us forever," said SkinCeuticals Co-Founders, Alden Pinnell and Russell Moon.

"We are honored to have had the chance to know and work with Dr. Pinnell over the years.  It was his breakthrough research that propelled the use of topical antioxidants within the skincare industry. Today, topical antioxidants are widely recognized as an essential component for maintaining and protecting healthy skin.  Most US dermatologists recommend that patients incorporate an antioxidant into their daily skincare routine. Everything he has taught us, as well as his passion for discovery, will continue to live on daily through all of us here at SkinCeuticals. I personally have grown and learned an enormous amount from Dr. Pinnell, and he will be dearly missed," said SkinCeuticals Global General Manager, Marc Toulemonde.

"Dr. Pinnell's philosophy and dedication to advancing science in the cosmeceutical landscape is unlike any we have ever seen, and he remains an inspiration for us today.  It is our esteemed privilege to have had the opportunity to learn from the 'Founding Father of Topical Antioxidants' and introduce a range of products that changed the way we care for our skin globally," said Brigitte Liberman, World Wide President, L'Oreal Active Cosmetic Division.

A graduate of Duke University's Trinity College, Dr. Pinnell earned his medical degree at Yale University and trained at the University of Minnesota Hospital, the National Institutes of Health, Massachusetts General Hospital, and Max Planck Institute for Biochemistry in West Germany. Dr. Pinnell earned his Bachelor of Arts degree in Chemistry at Duke University, where he graduated with Phi Beta Kappa academic honors.

Dr. Pinnell returned to Duke University in 1973 as an associate professor and investigator for the Howard Hughes Medical Institute at the Department of Medicine.  A visionary leader, Dr. Pinnell developed and implemented major strategic initiatives that facilitated the growth and prominence of Duke University's Division of Dermatology and culminated in the establishment of the nationally-recognized Department of Dermatology in 2009. He held the office of Chief of Dermatology for 15 years and retired in 2010 after 37 years of service. During his tenure, he trained over 100 residents, 22 research fellows, and left a legacy of 22 prominent dermatologists, including seven current department chairs, residency program directors, and associate department and vice chairs. Dr. Pinnell also served as a diplomat of the American Board of Dermatology and a member of the American Academy of Dermatology.

"Dr. Pinnell set the highest standard in teaching and research, and his mentorship provided me with the tools necessary to pursue my professional goals. We have lost a true mentor and dear friend," said Tina Alster, M.D., Director, Washington Institute of Dermatologic Laser Surgery Clinical Professor.

"Dr. Pinnell had an energy and enthusiasm for life and a knowledge of dermatology that was second to none. He will be missed by his many colleagues and by dermatologists globally," said Jean Krutmann, M.D., Professor of Dermatology and Environmental Medicine at the Heinrich-Heine-Universitat Dusseldorf.

Dr. Pinnell was accomplished in so many ways, but most particularly he would like to be remembered as a loving husband, father, grandfather, and ardent Duke Blue Devil fan. Dr. Pinnell is survived by his wife, Dr. Doren Madey Pinnell; three sons, Kevin, Alden, and Tyson; and five grandchildren.

A small, private ceremony was held on Monday, July 8th, in Duke University gardens. Later this year, a celebration of his life will be held at the Duke University Chapel, in conjunction with the dedication of the Pinnell Center for Investigative Dermatology. In lieu of flowers, contributions in Dr. Pinnell's honor may be made to Duke University (PO Box 90581, Durham, NC 27701). Contributions may be designated for the Pinnell Center for Investigative Dermatology, or for Duke Athletics, the Sarah P Duke Memorial Gardens, and/or Nasher Museum of Art.

SOURCE SkinCeuticals

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

icon3
440k+
Newsrooms &
Influencers
icon1
9k+
Digital Media
Outlets
icon2
270k+
Journalists
Opted In
GET STARTED

Modal title

Also from this source

GET VISIBLY FACE LIFTED WITH SKINCEUTICALS' NEWEST LIFTING SOLUTION A.G.E. INTERRUPTER ULTRA SERUM

GET VISIBLY FACE LIFTED WITH SKINCEUTICALS' NEWEST LIFTING SOLUTION A.G.E. INTERRUPTER ULTRA SERUM

SkinCeuticals, the #1 Medical Aesthetic Skincare Brand Worldwide*, announces the launch of A.G.E. Interrupter Ultra Serum, the latest science-backed...

SkinCeuticals Joins Forces with LaserAway to Enhance Post-Treatment Skincare

SkinCeuticals Joins Forces with LaserAway to Enhance Post-Treatment Skincare

SkinCeuticals, the leader in advanced, science-backed skincare, announces a partnership with LaserAway, the nation's leading provider of aesthetic...

More Releases From This Source

Explore

Pharmaceuticals

Pharmaceuticals

Medical Pharmaceuticals

Medical Pharmaceuticals

Obituaries

Obituaries

News Releases in Similar Topics

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2025 Cision US Inc.